PROPANC BIOPHARMA, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
PROPANC BIOPHARMA, INC. (PPCB) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent of 2.48% for the 12-month period ending 2018-06-30, per its 10-K filed 2018-09-17.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch · last filed 2018-09-17
- PROPANC BIOPHARMA, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2018 was 2.48%, a 33.69% decline from fiscal 2017.
- PROPANC BIOPHARMA, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2017 was 3.74%, a 392.11% increase from fiscal 2016.
- PROPANC BIOPHARMA, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2016 was 0.76%, a 65.77% decline from fiscal 2015.
- PROPANC BIOPHARMA, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2015 was 2.22%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent 12 month |
|---|---|
| 2018-06-30 | 2.48% 10-K · filed 2018-09-17 |
| 2017-06-30 | 3.74% 10-K · filed 2018-09-17 |
| 2016-06-30 | 0.76% 10-K · filed 2017-09-28 |
| 2015-06-30 | 2.22% 10-K · filed 2016-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |